Steve Schonfeld’s Guardant Health GH Stock Holding History

Steve Schonfeld’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$308K	–	2753
2022 Q3	$308K	Buy	+50,000	New	+$2.57M	﹤0.01%	2063

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Steve Schonfeld's GH Position: Q2 2026 in Review

Steve Schonfeld increased its Guardant Health (GH) stake by 150% in Q2 2026, buying an estimated $11.7M and bringing the position to 179,482 shares worth $26.9M. The position accounts for 0.1% of the portfolio, ranked #185.

Steve Schonfeld first reported a position in GH in Q4 2018 and has held it in 18 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Steve Schonfeld held 179,482 shares of Guardant Health worth $26.9M as of Q2 2026.
Steve Schonfeld bought 107,798 Guardant Health shares in Q2 2026, an estimated $11.7M.
Guardant Health made up 0.1% of Steve Schonfeld's portfolio in Q2 2026, its #185 holding.
Steve Schonfeld first reported a position in Guardant Health in Q4 2018 and has held it in 18 quarters since.
595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.